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A simple spectrophotometric method for the determination of N-acetyl-L-cysteine (NAC) and N-(2-mercaptopropionyl)glycine
(MPG) in pharmaceutical preparations was developed, validated, and used. The proposed equilibrium method is based on a
coupled two-step redox and complexation reaction. In the ﬁrst step, Fe(III) is reduced to Fe(II) by NAC or MPG. Subsequently,
Fe(II) is complexed with 2,4,6-tripyridyl-s-triazine (TPTZ). Several analytical parameters of the method were optimized for NAC
and MPG analysis in the concentration range from 1.0μM to 100.0μM. Regression analysis of the calibration data showed a good
correlation coeﬃcient (0.9999). The detection limit of the method was 0.14μM for NAC and 0.13μM for MPG. The method was
successfully applied to quantify NAC and MPG in pharmaceutical preparations. No interferences were observed from common
pharmaceutical excipients.
1.Introduction
N-Acetyl-L-cysteine (NAC) is an endogenous aminothiol pr-
esent both in human plasma and in urine [1]. N-(2-Mercap-
topropionyl)glycine (MPG), also known as tiopronin, is a
synthetic aminothiol antioxidant. NAC has been in clinical
use for more than 40 years, primarily as a mucolytic agent
in a variety of respiratory illness. Intravenous and oral admi-
nistration of NAC have been extensively used in the manage-
ment of paracetamol (acetaminophen) poisoning [1]. MPG
is primarily used in the treatment of cystinuria [2], but stu-
dieshaveshownthatMPGcanbeusedasachelating,cardio-
protecting, and radioprotecting agent [3], as well as an
antidote to heavy metal poisoning [4].
A number of electrochemical [5–9], ﬂuorometric [10–
12], chemiluminescence [13–15], and liquid chromato-
graphic [16–18] methods have been developed for the
determination of NAC and MPG in biological samples and
pharmaceuticals. Some of these methods are in part time
consumingorrequireexpensiveequipment.Otherpublished
methods suﬀer from lack of selectivity and sensitivity.
Spectrophotometry is the most widely used technique in
pharmaceutical analysis because it is simple, economic,
and easily available to most quality control laboratories.
Spectrophotometric methods have also been reported for
the determination of NAC and MPG in pharmaceutical
formulations [19–25].
A coupled redox-complexation reaction has been
reported for the spectrophotometric analysis of NAC and
MPG using 1,10-phenanthroline as the chromogenic reagent
[24]. In the present work, we report a simple and cost-
eﬀective spectrophotometric method for the reliable analysis
of NAC and MPG in pharmaceutical formulations. The
method is also based on the coupled redox-complexation
reaction between NAC or MPG and Fe(III) but uses 2,4,6-
tripyridyl-s-triazine (TPTZ) as the chromogenic reagent.
Collins et al. have introduced TPTZ as chromogenic reagent
for determination of Fe(II) [26]. The Fe(II) complex with
TPTZ has a twice higher molar absorptivity coeﬃcient (2.2
× 104 Lmol −1 cm−1) than the Fe(II) complex with 1,10-
phenanthroline (1.1 × 104 Lmol −1 cm−1). TPTZ provides
higher selectivity, linearity, and sensitivity of the method.2 International Journal of Analytical Chemistry
2.MaterialandMethods
2.1. Materials. All spectrophotometric studies were carried
out on an ultraviolet-visible, double-beam spectrophotome-
ter (UV-1601 SHIMADZU, Kyoto, Japan), and using 1cm
quartz cells. The spectrophotometer was coupled to a per-
sonal computer. Measurements of pH were carried out with
a Mettler Toledo SevenMulti potentiometer (Mettler Toledo,
Schwerzenbach, Switzerland) equipped with a combined
glass electrode Mettler Toledo In Lab 413. A thermostated
water bath (MGW Lauda, Germany) was used to keep a
constant cuvette temperature of 25 ± 0.5◦C.
2.2. Chemicals and Reagents. All chemicals were of analy-
tical-reagent grade, and solutions were prepared in MilliQ
deionised water. All stock solutions were stored at 4◦Ci n
dark bottles. Separate 10mM stock solutions of NAC and
MPG were prepared by dissolving 163.2mg (1mmol) of
NAC (Merck, Darmstadt, Germany) or 163.2mg (1mmol)
of MPG (Sigma-Aldrich, St. Louis, USA) in deionised water
up to 100.0mL volume and stored in the dark bottle at 4◦C.
Dilutions were prepared daily in deionised water.
Stock solution of Fe(III) (10mM) was prepared by
dissolving 270.3mg (1mmol) of FeCl3 × 6H 2O (Kemika,
Zagreb, Croatia) in 50.0mL deionised water. Then 0.5mL of
concentrated HCl was added and the volume was adjusted to
100.0mL with deionised water.
A stock solution of 10mM TPTZ (Merck, Darmstadt,
Germany) was prepared by dissolving 312.3mg (1mmol)
TPTZ in 2.0mL of a 6.0M HCl, followed by addition of
deionised water up to a total volume of 100.0mL.
Acetate buﬀer (0.5M) was used to cover the pH range
3.2–4.0. For solutions of pH 1.0 and 2.0, 0.1M HCl and
0.01M HCl were used, respectively.
Two diﬀerent pharmaceutical formulations of NAC were
analysed by the present spectrophotometric method, that is,
Fluimukan 200mg granules, and Fluimukan Akut 600mg
dispersible tablets (Lek, Ljubljana, Slovenia). The content
o fﬁ v eg r a n u l e sw a sp o w d e r e db ym e a n so fam o r t a r .A n
accurately weighed portion of the powder containing about
200mg of NAC was transferred into a 500mL volumetric
ﬂask, and NAC was dissolved in and diluted to the nominal
volume with deionised water. One dispersible tablet was
dissolved in 1000mL of deionised water.
Ten tablets of the MPG-containing drug Captimer (MIT
Gesundheit GmbH, Germany) were weighed and pulverised.
A powder quantity equivalent to 100mg of MPG was
dissolved in 300mL of deionised water, ﬁltered through ﬁlter
paper(Blueribbon,S&S,Germany),andtheﬁltratecollected
in a 500mL volumetric ﬂask was diluted by deionised water
to the nominal volume. It is noteworthy that such solutions
are not stable and should be analysed within 24 hours.
These solutions were further diluted quantitatively with
watertoobtainsuitableconcentrationsfortheanalysisbythe
proposed spectrophotometric method.
2.3. Procedures. Acetate buﬀer (20.0mL, pH 3.6) was pipet-
ted into a 25.0mL calibrated ﬂask. Then 1.25mL of 10.0mM
Fe(III), 1.25mL of 10.0mM TPTZ, and 1.0mL of NAC
or MPG solutions were added. The ﬂask with reaction
solution was ﬁlled to the nominal volume with deionised
water, mixed well, and kept at room temperature (about
25◦C) for 30min (MPG) or 60min (NAC). The absorbance
of the produced Fe(II)-TPTZ complex was measured at
λ = 593nm against a blank solution, prepared in the
same manner with 1.0mL water instead of 1.0mL sample
solution. The absorbance of the obtained complex remains
constant for at least 24 hours. NAC and MPG concentrations
in pharmaceutical preparations were determined by using
daily prepared calibration curves. The eleven solution of
everyanalytewerepreparedfortheconcentrationrangefrom
1.0μMto100.0μM.Thestandardsolutionswerepreparedby
appropriate serial dilution from the stock solutions.
3. Results and Discussion
The proposed method is based on the coupled redox-
complexation reaction. In the ﬁrst (redox) step of the
reaction (see (1)), RSH compound (NAC or MPG) reduces
Fe(III) to Fe(II) whereas RSH molecules themselves oxidize
to thiyl radicals RS• which combine to form the disulﬁde
RSSR. In the second step of the reaction (see (2)), in situ
formed Fe(II) is immediately complexed by 2 molecules
of TPTZ to form the deep-blue coloured, highly stable
Fe(TPTZ)2
2+ complex which absorbs light at λmax at 593nm.
The net overall reaction can be expressed by reaction (3):
Fe3+ +RSH Fe2+ +H + +RS
• (1)
Fe2+ +2 TPTZ  Fe(TPTZ)2
2+ (2)
2F e 3++2 RSH+4 TPTZ 2F e (TPTZ)2
2++RSSR+2 H+
(3)
Krishnamurti and Huang have reported that the com-
plexation of TPTZ is speciﬁc for Fe(II) so that this reaction
can be performed in the presence of large amounts of Fe(III)
[27]. The results of the present study conﬁrm these previous
results for the drugs NAC and MPG serving as the reducing
agents.
In the literature, we were not able to ﬁnd the standard
reduction potential for NAC and MPG. However, the
calculated formal potential of the Fe(III)/Fe(II) couple of
0.578V, equations (4)a n d( 5) indicate that its oxidizing
p o w e ri ns o l u t i o nw i t hT P T Zi sm o r en e g a t i v et h a ni n
solution with 1,10-phenanthroline (1.197V). This means
that the proposed method with the TPTZ is selective for the
determination of NAC and MPG. Thiols or other reducing
substances with standard (formal) potentials higher than
0.6V would not interfere in the proposed method (see (6));
E0 
1 = E0
Fe3+/Fe2+ −
0.0592
2
·log

αFe2+
αFe3+ ·[TPTZ]
2
2
,( 4 )
E0 
1 = 0.771V − 0.0592 · log
1.265 ×10−5
0.077 ·(3 ×10−4)
2 = 0.578V
(5)
E0 
2 = E0
RSSR/RSH −0.0592 ·pH. (6)International Journal of Analytical Chemistry 3
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Figure 1: Eﬀect of the pH value of the reaction mixture on the
absorbance of the Fe(TPTZ)2
2+ complex. For each pH value, the
absorbancewasrecorded30minutesafterbeginningofthereaction.
Triplicate measurements, practically the same, were done for each
pH value. Initial concentrations were 40μMf o rM P G ,0 . 2m Mf o r
Fe(III), and 0.2mM for TPTZ. Reaction temperature was 25◦C.
In previous work, we found that the initial redox-
complexation reaction rate is higher with MPG compared to
NAC [28, 29]. In the coupled redox-complexation reaction
withMPG,thesteadystatevalueoftheabsorbanceisreached
after 30min while in the reaction with NAC the steady
state value of the absorbance is reached after 60min. With
both thiols, maximum absorbance remains stable for at least
24 hours. This observation is of particular importance in
quantitative analyses.
3.1. Eﬀect of pH. Equation (6) indicates that the potential
for the redox system RSH/RSSR depends upon the pH value
of the reaction mixture. The eﬀect of the pH was therefore
investigated over the range 1.0–4.0 using 0.1M HCl for pH
1, 0.01M HCl for pH 2, and acetate buﬀer for the pH values
3.2, 3.5 and 3.6. In this experiment MPG was used as the
reducing agent in the coupled redox-complexation reaction.
The results are shown in Figure 1.
The absorbance at 593nm increased with increasing
pH up to the value of 3.6. However, precipitation of
iron hydroxide occurred at the pH above 3.8. Therefore,
ab u ﬀered reaction medium of pH 3.6 was chosen as a
compromise for keeping Fe(III) in solution and achieving
quantitative formation of the Fe(TPTZ)2
2+ complex which
is stable in the pH range 3.4–5.8 [26].
3.2. Eﬀect of the Concentration of Fe(III) and TPTZ. The inﬂ-
uence of the Fe(III) concentration on the determination
of NAC and MPG at the ﬁxed concentration of 40μM
each was studied in the concentration range from 20μM
to 400μM, allowing a molar ratio Fe(III)/RSH from 0.5
to 10. In Figure 2, the absorbance measured at 593nm is
plotted versus the molar Fe(III)/RSH ratio for NAC and
MPG. Figure 2 shows that the reaction can be forced to
c(Fe3+)/c(RSH)
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Figure 2: Eﬀect of the Fe(III) concentration on the absorbance at
593nm for the ﬁxed concentration of 40μM for the thiol (RSH)
compound, that is, NAC or MPG, at pH 3.6 and 25◦C. The
concentration of TPTZ was 0.2mM.
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Figure 3: Eﬀect of the TPTZ concentration on the absorbance at
593nm for the ﬁxed concentration of 40μM of the thiol (RSH)
compound, that is, NAC or MPG, at pH 3.6 and 25◦C. The
concentration of Fe(III) was 0.2mM.
completion by increasing the Fe(III)/RSH ratio, for instance
by increasing the Fe(III) concentration.
The inﬂuence of the TPTZ concentration on the analysis
of NAC and MPG at the ﬁxed concentration of 40μMR S H
compound was studied in the range from 20μM to 400μM
allowing a TPTZ/RSH molar ratio of 0.5 to 10. Figure 3
shows that absorbance increased with increasing TPTZ/RSH
molar ratio, that is, with increasing TPTZ concentration, to
reach its maximal value at a molar excess of ﬁve.
3.3. Eﬀect of the Temperature. The eﬀect of the reaction
temperature on the signal intensity was examined by varying
the temperature from 25◦Ct o4 0 ◦C using the thermostated4 International Journal of Analytical Chemistry
Table 1: Spectral characteristics and analytical parameters of the method for NAC and MPG under optimum reaction conditions.
Analytical parameter NAC MPG
λmax (nm) 593 593
ε (M−1 cm−1)(a) 2.2 × 104 2.2 × 104
Sandell’s sensitivity (μgc m −2)(a) 7.5 × 10−3 7.6 × 10−3
m (slope) ± SD 2.14 × 104± 0.0077 2.15 × 104± 0.0074
z (intercept) ± SD 0.0025 ± 0.0026 0.0036 ± 0.0033
Linear regression coeﬃcient (R2) 0.9999 0.9999
Beer’s law range (μM) 1.0 to 100.0 1.0 to 100.0
Number of points/replicates 11/3 11/3
Detection limit (μM)(b) 0.14 0.13
Quantitation limit (μM)(c) 1.0 1.0
(a)Average of eleven determinations.
(b)Detection limit = 3s b/m (three standard deviations for a blank divided by the slope of the calibration curve).
(c)Quantitation limit = at least 10sb/m (ten standard deviations for a blank divided by the slope of the calibration curve).
Table 2: Determination of NAC and MPG in their pharmaceutical
formulations by the proposed spectrophotometric equilibrium
method and by a literature method [24].
Pharmaceutical
preparation Present work(a) mg Method from
[24](a) mg
Fluimukan(b) (NAC) 202.0 ± 1.9 202.9 ± 3.2
Fluimukan Akut(c) (NAC) 605.9 ± 6.1 606.9 ± 7.2
Captimer(d)(MPG) 99.2 ± 0.8 99.0 ± 1.0
(a)Average of three determinations ± SD.
(b)Granules containing 200mg NAC and excipients.
(c)Dispersible tablets containing 600mg NAC and excipients.
(d)Tablets containing 100mg MPG and excipients.
water pump. We found that the reaction rate increased
by elevating reaction temperature (see [28, 29]). Since
the proposed method is an equilibrium method, signal is
recorded when the reaction reaches the state of equilibrium.
The signal intensity in the state of equilibrium is the same
for all the examined temperatures. However, for practical
reasons the ambient laboratory temperature of 25◦Cw a s
ﬁnally used.
3.4. Analytical Characteristics. The linearity of the method
was investigated under the optimized conditions for NAC
and MPG in the concentration range from 1.0 to 100.0μM.
Straight lines were obtained from linear regression analysis
of the absorbance at 593nm and the drug concentration
(Table 1). Expectedly, very similar results were obtained for
NAC and MPG. The lowest quantiﬁable concentration of
NAC and MPG by this method was 1.0μMe a c h .
3.5. Interferences Studies. The eﬀect of some possible inter-
fering cations and anions on the analysis of a ﬁxed concen-
tration of 40.0μM for NAC and MPG was investigated for
the maximum molar ratio of foreign ions. The inﬂuence of
excipients that can commonly accompany NAC and MPG in
pharmaceutical formulations was also studied.
The tolerance is deﬁned as the foreign-ion/excipient
concentration causing an error smaller than ±5% for the
determination of the analyte of interest. The tolerable con-
centration of KNO3 and Na2SO4 was 40.0mM (molar ratio,
1000:1). The tolerable concentration of glucose, fructose,
sucrose, boric acid, and acetic acid was 20.0mM (molar
ratio, 500:1). Thus, the commonly excipients glucose,
fructose, and sucrose do not interfere with the analysis
of NAC and MPG because they essentially do not react
with the oxidizing agents. It should be emphasized that
the contaminant/analyte concentration ratios studied in the
present work are much higher than those normally found in
commercial pharmaceutical products.
The tolerable concentration of some other thiols, that is,
D-penicillamine, L-glutathione, and L-cysteine, was 40.0μM
(molar ratio, 1:1). These experiments conﬁrmed above-
mentioned theoretical consideration. Thiols or other reduc-
ing substances with standard (formal) potentials higher than
0.6V would not interfere in the proposed method.
3.6. Application of the Method. In order to evaluate the
potential of the proposed method to the analysis of real
samples, the method was applied to three pharmaceutical
formulations of the drugs NAC and MPG. The results of
these analyses are presented in Tables 2 and 3.
For comparison, the spectrophotometric method
reported by Raggi et al. [24] was used for the parallel
assay of the same batch tablets. These authors used 1,10-
phenantroline as an chromogenic reagent, instead of TPTZ
which is used in the present work. As shown in Table 2, there
were no signiﬁcant diﬀerences between the values obtained
by the reported method [24] and those obtained by the
proposed method (P>0.1, Student t-test). This actually
suggests that the proposed method is accurate and precise as
the earlier reported method [24].
The accuracy of the method was further ascertained
through the recovery studies. To the drug solutions of the
granules or the tablet powder, the standard solutions of
the synthetic NAC or MPG were added at four diﬀerentInternational Journal of Analytical Chemistry 5
Table 3: Accuracy (recovery, %) of the proposed method for the determination of NAC and MPG in two pharmaceutical formulations.
Sample Added μgm L −1 Found(a)μgm L −1 Recovery %
Fluimukan (NAC)
0.0 200.1 ± 0.4 Not applicable
50.0 249.1 ± 1.6 98.2
100.0 301.2 ± 1.8 101.2
150.0 348.2 ± 2.1 98.8
200.0 404.4 ± 2.2 102.2
Captimer (MPG)
0.0 100.2 ± 0.6 Not applicable
50.0 149.3 ± 1.1 98.6
100.0 198.4 ± 1.3 98.4
150.0 252.5 ± 2.4 101.7
200.0 303.9 ± 3.1 101.9
(a)Average of three determinations ± SD.
Table 4: Comparison of the equilibrium spectrophotometric methods for NAC and MPG determination.
Analyte Reagent(s) used λmax (nm) Beer’s law range (μM) ε (M−1 cm−1) Reference
NAC, MPG, penicillamine Fe(III)/1,10-phenanthroline 515 4.0–80.0 1.1 × 104 [24]
NAC PdCl2 375 24.5–400.0 Not reported [23]
NAC o-phthalaldehyde/isoleucine 335 3.0–300.0 6.3 × 104 [22]
Cysteine, NAC Fe(III)/ferrozine 562 0.1–36.8 2.3 × 104 [21]
NAC IO
−
3 /leucoxylenecyanol 613 1.2–9.8 9.6 × 104 [19]
NAC MPG Fe(III)/TPTZ 593 1.0–100.0 2.2 × 104 Present work
concentrations. The total content was determined by the
proposed method. The recovery of added NAC or MPG was
98–102% (Table 3).
These results indicate that the proposed method is
accurate for the determination of NAC and MPG in their
commercially available pharmaceutical preparations without
any signiﬁcant interference by common pharmaceutical
excipients which do not absorb light in the visible region.
Performance characteristic of existing equilibrium spec-
trophotometric methods [19, 21–24] and the proposed
method are compared in Table 4.
The proposed method is free from drastic experimental
conditions such as heating unlike some of reported methods.
Some other thiol compounds do not interfere in the pro-
posedmethodatmolarratio1:1.Itisalsoworthmentioning
that the proposed method was performed in the visible
region (λ = 593nm) away from the UV-absorbance of the
UV-absorbing interfering excipient materials, which might
be dissolved from pharmaceutical formulations.
4. Conclusion
Time, cost, and eﬃciency are essential considerations in
pharmaceutical industry. Undoubtedly, HPLC is one of the
most widely used techniques in routine analysis of pharma-
ceuticals, but it involves expensive instrumental set which
many laboratories in developing and underdeveloped coun-
tries can not aﬀord. The proposed equilibrium spectropho-
tometric method based on the coupled redox-complexation
reaction of the thiol drug NAC or MPG with Fe(III) and
TPTZ can be applied in every analytical laboratory as a
reliable method for the determination of NAC or MPG in
pharmaceutical preparations. Due to the use of TPTZ fast
colour development reaction is easily conducted at the room
temperature. The coloured Fe(TPTZ)2
2+ complex is stable in
anextendedperiodoftimeupto24hours.Regularexcipients
and additives present in the pharmaceutical preparations of
NAC and MPG do not interfere in this method.
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